NO140579C - Fremgangsmaate ved fremstilling av renset albumin fra en albuminloesning ved termisk koagulering i naervaer av kaprylationer - Google Patents

Fremgangsmaate ved fremstilling av renset albumin fra en albuminloesning ved termisk koagulering i naervaer av kaprylationer

Info

Publication number
NO140579C
NO140579C NO2749/73A NO274973A NO140579C NO 140579 C NO140579 C NO 140579C NO 2749/73 A NO2749/73 A NO 2749/73A NO 274973 A NO274973 A NO 274973A NO 140579 C NO140579 C NO 140579C
Authority
NO
Norway
Prior art keywords
albumin
caprylations
pureed
preparing
procedure
Prior art date
Application number
NO2749/73A
Other languages
English (en)
Other versions
NO140579B (no
Inventor
Robert Plan
Jacques Liautaud
Marie-France Makula
Paule Gattel
Jean Pla
Andre Debrus
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of NO140579B publication Critical patent/NO140579B/no
Publication of NO140579C publication Critical patent/NO140579C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid
NO2749/73A 1972-07-05 1973-07-04 Fremgangsmaate ved fremstilling av renset albumin fra en albuminloesning ved termisk koagulering i naervaer av kaprylationer NO140579C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7224311A FR2190437B1 (no) 1972-07-05 1972-07-05

Publications (2)

Publication Number Publication Date
NO140579B NO140579B (no) 1979-06-25
NO140579C true NO140579C (no) 1979-10-03

Family

ID=9101388

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2749/73A NO140579C (no) 1972-07-05 1973-07-04 Fremgangsmaate ved fremstilling av renset albumin fra en albuminloesning ved termisk koagulering i naervaer av kaprylationer

Country Status (17)

Country Link
US (1) US3992367A (no)
JP (1) JPS5312965B2 (no)
AR (1) AR195041A1 (no)
BE (1) BE801888A (no)
BR (1) BR7305002D0 (no)
CA (1) CA1028320A (no)
DE (1) DE2333883C3 (no)
DK (1) DK134425B (no)
ES (1) ES416597A1 (no)
FR (1) FR2190437B1 (no)
GB (1) GB1441751A (no)
LU (1) LU67931A1 (no)
NL (1) NL179874C (no)
NO (1) NO140579C (no)
RO (1) RO64629A (no)
SE (1) SE421997B (no)
SU (1) SU591126A3 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415079C3 (de) * 1974-03-28 1980-02-14 Plasmesco Ag, Zug (Schweiz) Verfahren zum Isolieren von Albumin aus Blutplasma
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
US4197238A (en) * 1977-04-12 1980-04-08 The Green Cross Corporation Method of preparation of human albumin using polyethylene glycol
US4164496A (en) * 1978-08-23 1979-08-14 American National Red Cross Preparation of albumin using PEG and EDTA
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4222934A (en) * 1979-04-12 1980-09-16 American National Red Cross Preparation of albumin using ethanol
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
JPS6152702U (no) * 1984-09-12 1986-04-09
JPS62294621A (ja) * 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US4791191A (en) * 1987-11-12 1988-12-13 Plasmatech Corporation Depyrogenation of clinical albumin
FR2632308B1 (fr) * 1988-06-07 1991-08-16 Fondation Nale Transfusion San Procede et installation de fractionnement en continu de proteines vegetales animales ou humaines
JPH0253505U (no) * 1988-10-12 1990-04-18
US5277818A (en) * 1988-10-31 1994-01-11 The Green Cross Corporation Albumin preparation and process for preparing the same
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) * 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
JP4935242B2 (ja) * 2006-08-24 2012-05-23 ニプロ株式会社 脂肪酸を含有するｓ−ニトロソタンパク質とその製法
WO2018165766A1 (en) * 2017-03-16 2018-09-20 Therapure Biopharma Inc. Method for purification of albumin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US2705230A (en) * 1949-09-23 1955-03-29 Allen F Reid Method of purifying albumin
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US2765299A (en) * 1952-06-27 1956-10-02 Armour & Co Recovery of serum albumin
US2761810A (en) * 1954-07-22 1956-09-04 Ortho Pharma Corp Preparation of blood fraction for use in rh testing procedures
US2958628A (en) * 1957-02-21 1960-11-01 Cutter Lab Heat treatable plasma protein product and method of preparation
US3100737A (en) * 1958-02-05 1963-08-13 Auerswald Wilhelm Method of preparing a plasma protein solution free of active hepatitis virus and product produced thereby
US3497492A (en) * 1968-04-02 1970-02-24 American Cyanamid Co Preparation of placental albumin
JPS5220524B1 (no) * 1968-11-02 1977-06-04

Also Published As

Publication number Publication date
FR2190437A1 (no) 1974-02-01
DK134425C (no) 1977-04-12
JPS5312965B2 (no) 1978-05-06
CA1028320A (en) 1978-03-21
NL179874B (nl) 1986-07-01
NO140579B (no) 1979-06-25
RO64629A (fr) 1979-02-15
NL7309361A (no) 1974-01-08
US3992367A (en) 1976-11-16
DE2333883B2 (de) 1982-09-16
LU67931A1 (no) 1975-04-11
ES416597A1 (es) 1976-03-01
BR7305002D0 (pt) 1974-08-15
BE801888A (fr) 1974-01-04
SU591126A3 (ru) 1978-01-30
GB1441751A (en) 1976-07-07
DK134425B (da) 1976-11-08
FR2190437B1 (no) 1975-08-08
AR195041A1 (es) 1973-08-30
DE2333883A1 (de) 1974-01-31
JPS4985219A (no) 1974-08-15
NL179874C (nl) 1986-12-01
SE421997B (sv) 1982-02-15
DE2333883C3 (de) 1983-05-11

Similar Documents

Publication Publication Date Title
NO140579C (no) Fremgangsmaate ved fremstilling av renset albumin fra en albuminloesning ved termisk koagulering i naervaer av kaprylationer
SE382059B (sv) Forfarande for framstellning av nya substituerade piperidinderivat
SE385585B (sv) Forfarande for framstellning av 1-alkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat
SE373371B (sv) Forfarande for framstellning av 1-aminoalken-1,1-difosfonsyror eller salter derav
SE405121B (sv) Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter
SE7611410L (sv) Forfarande for framstellning av nya derivat av penam-3-karboxylsyra
SE394426B (sv) Forfarande for framstellning av nya heptapeptider med gastrinverkan
SE399268B (sv) Forfarande for framstellning av nya purinnukleosidderivat
DK120996B (da) Analogifremgangsmåde til fremstilling af piperidinderivater eller syreadditionssalte deraf.
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE395885B (sv) Forfarande for framstellning av nya kortikotropinpeptider
SE397088B (sv) Forfarande for framstellning av nya 2-propanolderivat
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
DK138117B (da) Analogifremgangsmåde til fremstilling af isoindolinderivater eller syreadditionssalte deraf.
NO138947C (no) Fremgangsmaate ved fremstilling av 2-alkoxy-5-alkylsulfonyl-benzoesyrer
DK119110B (da) Fremgangsmåde til fremstilling af venstredrejende indolderivater eller syreadditionssalte heraf.
IT973248B (it) Monoazocoloranti resistenti al calore e procedimento per la loro preparazione
NO139890C (no) Fremgangsmaate ved fremstilling av n5 -methyltetrahydrohomofolinsyre
DK131149B (da) Analogifremgangsmåde til fremstilling af 4-hydroxy-cinnolincarboxylsyrer eller salte deraf.
DK135835B (da) Analogifremgangsmåde til fremstilling af substituerede alkensyrederivater eller salte deraf.
NO144068C (no) Fremgangsmaate ved fremstilling av butyrofenonderivater
SE404361B (sv) Forfarande for framstellning av nya 1-fenyl-3hydroxi-3-metyl-triazener
SE387949B (sv) Forfarande for framstellning av nya piperazinyl-tiazolderivat